|
|
 |
|
Viewing report
|
|
|
|
Orthobiologics - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017
GlobalData, Aug 2011, Pages: 107
Orthobiologics - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017
Summary
GlobalData’s new report, “Orthobiologics - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017” provides key data, information and analysis on the global orthobiologics market. The report provides market landscape, competitive landscape and market trends information on the orthobiologics market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market dynamics. The report also reviews the competitive landscape and technology offerings.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.
Scope
- Key geographies covered include the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia, and Brazil.
- Key segments covered include Bone Allografts, Bone Graft Substitutes, Bone Growth Stimulators, DBM and Viscosupplementation.
- Annualized market revenues data from 2003 to 2010, forecast forward for 7 years to 2017. Company shares data for 2010.
- Qualitative analysis of key market trends, market drivers, and restraints by each category within orthobiologics market.
- The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies.
- Key players covered include Medtronic, Genzyme Corporation, DePuy and Synthes.
Reasons to buy
- Develop business strategies by understanding the trends and developments that are driving the orthobiologics market globally.
- Design and develop your product development, marketing and sales strategies.
- Develop market-entry and market expansion strategies.
- Identify key players best positioned to take advantage of the emerging market opportunities.
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
- What’s the next big thing in the orthobiologics market landscape? – Identify, understand and capitalize.
- Make more informed business decisions from the insightful and in-depth analysis of the global orthobiologics market and the factors shaping it.
|
|
|
|
